Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

CONTEXT: For patients with metastatic papillary thyroid carcinoma (PTC) refractory to radioactive iodine (RAI) treatment, systemic chemotherapy has limited efficacy. Such tumors frequently harbor BRAF V600E, and this alteration may predict responsiveness to vemurafenib treatment. OBJECTIVE: We repor...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ali, Siraj M., He, Je, Carson, Wade, Stephens, Phil J., Fiorillo, Joseph, Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Miller, Vincent A., Sharman, Jeffrey
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2014
Témata:
Published online: May, 2014
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067722/
https://ncbi.nlm.nih.gov/pubmed/24987354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000363377
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky